Results 251 to 260 of about 4,505,998 (338)
ABSTRACT Objectives Repetitive transcranial magnetic stimulation (rTMS) is a non‐invasive brain stimulation strategy with a demonstrated potential to reinforce the residual pathways after a spinal cord injury (SCI). A preclinically tested high‐frequency (15 Hz) rTMS (15 Hz rTMS) protocol was shown to induce corticospinal tract axon regeneration growth ...
Nabila Brihmat +8 more
wiley +1 more source
A dynamical model of drinking and smoking with optimal control analysis. [PDF]
Wireko FA +5 more
europepmc +1 more source
Optimal feedback control of the radioactive voltage standard
D.W. Braudaway
openalex +2 more sources
ABSTRACT Objective To investigate the overall use of prescription medications among individuals with multiple sclerosis compared to the general population, with a focus on treatments beyond disease‐modifying therapies. Methods We conducted a nationwide, registry‐based study in Denmark.
Josefine Windfeld‐Mathiasen +4 more
wiley +1 more source
Generalization of Optimal Control Saturation Pulse Design for Robust and High CEST Contrast
Stilianu C +3 more
europepmc +1 more source
Optimal control prevents itself from eradicating stochastic disease epidemics. [PDF]
Russell R, Cunniffe NJ.
europepmc +1 more source
ICU‐EEG Pattern Detection by a Convolutional Neural Network
ABSTRACT Objective Patients in the intensive care unit (ICU) often require continuous EEG (cEEG) monitoring due to the high risk of seizures and rhythmic and periodic patterns (RPPs). However, interpreting cEEG in real time is resource‐intensive and heavily relies on specialized expertise, which is not always available.
Giulio Degano +5 more
wiley +1 more source
Federated deep reinforcement learning-based urban traffic signal optimal control. [PDF]
Li M, Pan X, Liu C, Li Z.
europepmc +1 more source
ABSTRACT Objective Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression.
Taru M. Flagan +46 more
wiley +1 more source

